Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Tuesday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

Shares of NASDAQ:MTEX opened at $8.50 on Tuesday. The stock has a market capitalization of $15.98 million, a PE ratio of -7.08 and a beta of 1.20. Mannatech has a 1 year low of $7.50 and a 1 year high of $16.38. The firm has a fifty day moving average price of $8.71 and a 200 day moving average price of $8.86. The company has a current ratio of 1.07, a quick ratio of 0.51 and a debt-to-equity ratio of 0.09.

Institutional Investors Weigh In On Mannatech

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC raised its position in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 167.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,575 shares of the company’s stock after acquiring an additional 987 shares during the period. Tower Research Capital LLC TRC owned approximately 0.08% of Mannatech worth $27,000 as of its most recent SEC filing. 12.98% of the stock is owned by institutional investors and hedge funds.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.